Check Cap Ltd
Change company Symbol lookup
Select an option...
CHEK Check Cap Ltd
CSTL Castle Biosciences Inc
GIC Global Industrial Co
EQHA EQ Health Acquisition Corp
DLCAW Deep Lake Capital Acquisition Equity Warrant Exp 04 Jan 2026 *W EXP 01/04/2026
CDK CDK Global Inc
CNC Centene Corp
ONXXF Ontex Group NV
INDB Independent Bank Corp (Massachusetts)
IIII Insu Acquisition Corp III
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements


Based in Israel
Company profile

Check-Cap is a Israel-based clinical-stage medical diagnostics company developing. The Company develops C-Scan, capsule-based, system ingestible imaging for colorectal cancer screening.

Closing Price
$0.3353
Day's Change
-0.0227 (-6.34%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.3616
Day's Low
0.3308
Volume
(Average)
Volume:
530,353

10-day average volume:
565,732
530,353
Latest Earnings Met Consensus (Q4 ending 12/2021)Next Earnings Announcement
Q4
Announced April 6, 2022
-$0.06Q4 Estimate range
of 2 analysts
-$0.04 to -$0.02Q1 Earnings
will announce
(Unconfirmed) May 23, 2022

Quarterly Earnings History and Estimates

Hide high-low estimates
Draw trendlines

Draw up to 3 lines inside the chart.

Display:

UpdateCancel

CHEK's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.